{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:00:55Z","timestamp":1793822455882,"version":"4.6.1"},"reference-count":297,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017336","name":"Government of Italy Commission for the Selection of Excellence University Departments","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167761","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:42:45Z","timestamp":1741048965000},"page":"167761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sepsis and high-density lipoproteins: Pathophysiology and potential new therapeutic targets"],"prefix":"10.1016","volume":"1871","author":[{"given":"Cinzia","family":"Parolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167761_bb0005","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2025.167761_bb0015","first-page":"1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest."},{"issue":"2003","key":"10.1016\/j.bbadis.2025.167761_bb0020","first-page":"530","article-title":"SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"29","author":"Levy","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2025.167761_bb0030","series-title":"Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions","author":"WHO","year":"2020"},{"key":"10.1016\/j.bbadis.2025.167761_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jech-2018-210501","article-title":"Clinical and epidemiological variability in severe sepsis: an ecological study","volume":"72","author":"Vakkalanka","year":"2018","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.bbadis.2025.167761_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2014.04.001","article-title":"Sepsis: current dogma and new perspectives","volume":"40","author":"Deutschman","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/s-0033-1343894","article-title":"Sepsis and thrombosis","volume":"39","author":"Levi","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bbadis.2025.167761_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/joim.12331","article-title":"Endothelial barrier dysfunction in septic shock","volume":"277","author":"Opal","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/TA.0b013e31829de6cd","article-title":"Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis","volume":"75","author":"White","year":"2013","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.bbadis.2025.167761_bb0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/00365540310015935","article-title":"Cytokine cascade in sepsis","volume":"35","author":"Cavaillon","year":"2003","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.bbadis.2025.167761_bb0065","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","article-title":"Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment","volume":"25","author":"Zeni","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-induced immunosuppression","volume":"84","author":"Torres","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0075","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00003246-199708000-00015","article-title":"Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice","volume":"25","author":"Hotchkiss","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0085","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.2147\/DDDT.S500276","article-title":"Exploiting the zebrafish model for sepsis research: insights into pathophysiology and therapeutic potentials","volume":"18","author":"He","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbadis.2025.167761_bb0090","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2025.167761_bb0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/HCO.0b013e3283007ccd","article-title":"Acute effects of high-density lipoproteins: biochemical basis and clinical findings","volume":"23","author":"Chiesa","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/jpet.119.261719","article-title":"A compendium of the biological effects of apolipoprotein A-IMilano","volume":"372","author":"Parolini","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2025.167761_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113826","article-title":"Microarray analysis identifies human apoA-IMilano and apoA-II as determinants of the liver gene expression related to lipid and energy metabolism","volume":"433","author":"Ganzetti","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/smim.1998.0142","article-title":"Introduction: the role of innate immunity in the adaptive immune response","volume":"10","author":"Janeway","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0120","article-title":"Marine n-3 polyunsaturated fatty acids: efficacy on inflammatory-based disorders","volume":"262","author":"Parolini","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167761_bb0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF02284303","article-title":"Untersuchungen uber das Choleragift","volume":"11","author":"Pfeffer","year":"1982","journal-title":"Z Hyg."},{"key":"10.1016\/j.bbadis.2025.167761_bb0130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0029-1205597","article-title":"Untersuchungen uber das Infektionsfieber das Fiebergift der Bakterien","volume":"20","author":"Centanni","year":"1984","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.bbadis.2025.167761_bb0135","first-page":"25","article-title":"Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity","volume":"231","author":"Rietschel","year":"1987","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.193.3.393","article-title":"Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus","volume":"193","author":"Morath","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1924.02650330036014","article-title":"Scarlet fever toxin in preventive immunization","volume":"82","author":"Dick","year":"1924","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2025.167761_bb0150","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.2185544","article-title":"The staphylococcal enterotoxins and their relatives","volume":"248","author":"Marrack","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: an update","volume":"55","author":"McCormick","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/CMR.13.1.16","article-title":"Exotoxins of Staphylococcus aureus","volume":"13","author":"Dinges","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbadis.2025.167761_bb0165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1084\/jem.131.3.611","article-title":"A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock","volume":"131","author":"Kim","year":"1970","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0170","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/iai.21.3.753-763.1978","article-title":"Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock","volume":"21","author":"Schlievert","year":"1978","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2025.167761_bb0175","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/CMR.00104-12","article-title":"Staphylococcal and streptococcal superantigen exotoxins","volume":"26","author":"Spaulding","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbadis.2025.167761_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(08)60534-9","article-title":"Superantigens and their potential role in human disease","volume":"54","author":"Kotzin","year":"1993","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0185","series-title":"Superantigens: Molecular Biology, Immunology, and Relevance to Human Disease","first-page":"1","volume":"607","author":"Leung","year":"1997"},{"key":"10.1016\/j.bbadis.2025.167761_bb0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.immunol.17.1.435","article-title":"The structural basis of T cell activation by superantigens","volume":"17","author":"Li","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri1004","article-title":"Innate immune sensing and its roots: the story of endotoxin","volume":"3","author":"Beutler","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0200","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI62423","article-title":"Alarmins: awaiting a clinical response","volume":"122","author":"Chan","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb0205","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0210","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.4049\/jimmunol.164.7.3471","article-title":"Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages","volume":"164","author":"Akashi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0215","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","article-title":"Rafts defined: a report on the keystone symposium on lipid rafts and cell function","volume":"47","author":"Pike","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/77842","article-title":"Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation","volume":"1","author":"Anderson","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0225","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1194\/jlr.M006486","article-title":"Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol","volume":"51","author":"Zhu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0230","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167761_bb0235","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","article-title":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions","volume":"118","author":"Yvan-Charvet","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2025.167761_bb0240","doi-asserted-by":"crossref","first-page":"C1538","DOI":"10.1152\/ajpcell.00467.2009","article-title":"Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages","volume":"298","author":"Smythies","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0245","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0250","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","article-title":"High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide","volume":"122","author":"Suzuki","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2025.167761_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.179.1.269","article-title":"Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14","volume":"179","author":"Hailman","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0260","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0959-440X(98)80118-8","article-title":"The implications of the structure of the bactericidal\/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein","volume":"8","author":"Bruce","year":"1998","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/imm.13634","article-title":"Role of CD14 in human disease","volume":"169","author":"Sharygin","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.bbadis.2025.167761_bb0270","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.164.3.777","article-title":"Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum","volume":"164","author":"Tobias","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0275","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/171.3.639","article-title":"Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock","volume":"171","author":"Lendmann","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbadis.2025.167761_bb0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2016.11.007","article-title":"Reconstruction of LPS transfer Cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer","volume":"46","author":"Ryu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0285","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0295","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"Jin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0300","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jlb.67.4.508","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products","volume":"67","author":"Bowie","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0305","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0310","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.molcel.2014.03.012","article-title":"A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide","volume":"54","author":"Tan","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0315","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0320","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ni.1606","article-title":"Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2","volume":"9","author":"Kawagoe","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0325","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature08247","article-title":"Direct activation of protein kinases by unanchored polyubiquitin chains","volume":"461","author":"Xia","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0330","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","article-title":"TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway","volume":"103","author":"Dumitru","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ni1014","article-title":"Differential regulation of interleukin 1 receptor and toll-like receptor signaling by MEKK3","volume":"5","author":"Huang","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0340","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/md22010017","article-title":"The role of marine n-3 polyunsaturated fatty acids in inflammatory-based disease: the case of rheumatoid arthritis","volume":"22","author":"Parolini","year":"2024","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bbadis.2025.167761_bb0345","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri1630","article-title":"Negative regulation of toll-like receptor-mediated immune responses","volume":"5","author":"Liew","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0355","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.4049\/jimmunol.167.10.5887","article-title":"Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes","volume":"167","author":"Kawai","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0360","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ni774","article-title":"TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha\/beta-dependent gene expression in macrophages","volume":"3","author":"Toshchakov","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0365","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0370","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","volume":"171","author":"Sato","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0375","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni.1638","article-title":"Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses","volume":"9","author":"Ermolaeva","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0380","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature04369","article-title":"Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6","volume":"439","author":"Hacker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0385","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature04374","article-title":"Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response","volume":"439","author":"Oganesyan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0390","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.1136567","article-title":"Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity","volume":"315","author":"Tenoever","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-065X.2008.00734.x","article-title":"Function of Nod-like receptors in microbial recognition and host defense","volume":"227","author":"Franchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2025.167761_bb0400","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1086","article-title":"NODs: intracellular proteins involved in inflammation and apoptosis","volume":"3","author":"Inohara","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0405","doi-asserted-by":"crossref","first-page":"12955","DOI":"10.1074\/jbc.274.19.12955","article-title":"Human CARD4 protein is a novel CED-4\/Apaf-1 cell death family member that activates NF-kappaB","volume":"274","author":"Bertin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR gene family: a standard nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0415","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1210\/en.2018-01061","article-title":"NOD1: an interface between innate immunity and insulin resistance","volume":"160","author":"Rivers","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2025.167761_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006177","article-title":"Nod2: the intestinal gate keeper","volume":"13","author":"Al Nabhani","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2025.167761_bb0425","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/mi.2011.29","article-title":"NOD2, an intracellular innate immune sensor involved in host defense and Crohn\u2019s disease","volume":"4","author":"Strober","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0430","first-page":"477","article-title":"The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction","volume":"10","author":"Kufer","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0435","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.200502153","article-title":"Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition","volume":"170","author":"Barnich","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0440","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1126\/science.aau6391","article-title":"Palmitoylation of NOD1 and NOD2 is required for bacterial sensing","volume":"366","author":"Lu","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100097","article-title":"S-palmitoylation of NOD2 controls its localization to the plasma membrane","volume":"62","author":"Dixon","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0450","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2466-14-152","article-title":"Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages","volume":"14","author":"Juarez","year":"2014","journal-title":"BMC Pulm. Med."},{"issue":"1630\u20131641","key":"10.1016\/j.bbadis.2025.167761_bb0455","first-page":"1641","article-title":"ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn\u2019s disease pathogenesis","volume":"139","author":"Homer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167761_bb0460","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","article-title":"Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry","volume":"11","author":"Travassos","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0465","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0167-5699(94)90217-8","article-title":"The type II \u2018decoy\u2019 receptor: a novel regulatory pathway for interleukin 1","volume":"15","author":"Colotta","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.bbadis.2025.167761_bb0470","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nri2634","article-title":"Transcriptional control of the inflammatory response","volume":"9","author":"Medzhitov","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0475","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","article-title":"Mechanisms underlying ubiquitination","volume":"70","author":"Pickart","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0480","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1066","article-title":"Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors","volume":"5","author":"Chuang","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0485","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.167.3.1609","article-title":"Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide","volume":"167","author":"Abreu","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0490","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1126\/science.285.5428.736","article-title":"Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2","volume":"285","author":"Aliprantis","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb0495","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.4049\/jimmunol.168.9.4601","article-title":"Divergence of apoptosis-inducing and preventing signals in bacteria-faced macrophages through myeloid differentiation factor 88 and IL-1 receptor-associated kinase members","volume":"168","author":"Ruckdeschel","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0500","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature02405","article-title":"The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4","volume":"428","author":"Hsu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0505","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/geno.1997.4940","article-title":"Genetic structure and chromosomal mapping of MyD88","volume":"45","author":"Hardiman","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2025.167761_bb0510","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0960-9822(02)00712-1","article-title":"Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88","volume":"12","author":"Janssens","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0515","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.20021790","article-title":"Inhibition of interleukin 1 receptor\/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4","volume":"197","author":"Burns","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0520","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167761_bb0525","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.cellsig.2007.02.009","article-title":"Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling","volume":"19","author":"Su","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2025.167761_bb0530","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000158541","article-title":"The interleukin-1 receptor-associated kinase M selectively inhibits the alternative, instead of the classical NFkappaB pathway","volume":"1","author":"Su","year":"2009","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.bbadis.2025.167761_bb0535","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","article-title":"Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer","volume":"17","author":"Katso","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0540","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.67.1.481","article-title":"Phosphoinositide kinases","volume":"67","author":"Fruman","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0545","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood-2008-02-137430","article-title":"Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells","volume":"112","author":"Ohtani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.167761_bb0550","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s004240050815","article-title":"Involvement of adenylate cyclase and p70(S6)-kinase activation in IL-10 up-regulation in human monocytes by gp41 envelope protein of human immunodeficiency virus type 1","volume":"437","author":"Speth","year":"1999","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbadis.2025.167761_bb0555","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0560","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/00005344-199423005-00015","article-title":"Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury","volume":"23","author":"Soma","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0565","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167761_bb0570","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.febslet.2009.07.001","article-title":"Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation","volume":"583","author":"Badi","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2025.167761_bb0575","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn1408","article-title":"HIF1 and oxygen sensing in the brain","volume":"5","author":"Sharp","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167761_bb0580","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vph.2015.08.006","article-title":"Beta2-adrenergic activity modulates vascular tone regulation in lecithin: cholesterol acyltransferase knockout mice","volume":"74","author":"Manzini","year":"2015","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0585","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response","volume":"6","author":"Murray","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0590","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1074\/jbc.M609101200","article-title":"Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages","volume":"282","author":"Williams","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0595","doi-asserted-by":"crossref","first-page":"32124","DOI":"10.1074\/jbc.M203298200","article-title":"The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells","volume":"277","author":"Guha","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0600","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4049\/jimmunol.171.2.717","article-title":"Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide","volume":"171","author":"Martin","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0605","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0610","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/emboj.2010.268","article-title":"FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages","volume":"29","author":"Fan","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2025.167761_bb0615","doi-asserted-by":"crossref","first-page":"44295","DOI":"10.1074\/jbc.M111.258053","article-title":"Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1","volume":"286","author":"Brown","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0620","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1128\/MCB.00069-10","article-title":"Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages","volume":"30","author":"Chaurasia","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0625","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2009.06.024","article-title":"The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs","volume":"31","author":"Androulidaki","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0630","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1073\/pnas.1118579109","article-title":"Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine\/threonine kinases PI3K\/Akt","volume":"109","author":"Troutman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167761_bb0635","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1073\/pnas.1111957108","article-title":"B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K","volume":"109","author":"Ni","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167761_bb0640","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2010.08.055","article-title":"Identification of BCAP-(L) as a negative regulator of the TLR signaling-induced production of IL-6 and IL-10 in macrophages by tyrosine phosphoproteomics","volume":"400","author":"Matsumura","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.167761_bb0645","doi-asserted-by":"crossref","first-page":"30628","DOI":"10.1073\/pnas.2009778117","article-title":"TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation","volume":"117","author":"Irizarry-Caro","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167761_bb0650","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ni1110","article-title":"The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses","volume":"5","author":"Boone","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0655","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0660","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2008.02.002","article-title":"The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals","volume":"28","author":"Hitotsumatsu","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb0665","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35014038","article-title":"Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor","volume":"2","author":"Burns","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0670","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000485850","article-title":"Toll-interacting protein, Tollip, inhibits IL-13-mediated pulmonary eosinophilic inflammation in mice","volume":"10","author":"Ito","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.bbadis.2025.167761_bb0675","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1074\/jbc.M109537200","article-title":"Negative regulation of toll-like receptor-mediated signaling by Tollip","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0680","doi-asserted-by":"crossref","first-page":"39653","DOI":"10.1074\/jbc.M112.388009","article-title":"Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-\u03b2 signaling pathway","volume":"287","author":"Zhu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0685","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00109-020-01999-4","article-title":"Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease","volume":"99","author":"Li","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bbadis.2025.167761_bb0690","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BJ20102160","article-title":"The C2 domain of Tollip, a Toll-like receptor signalling regulator, exhibits broad preference for phosphoinositides","volume":"435","author":"Ankem","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2025.167761_bb0695","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10059-010-0145-5","article-title":"Backbone (1)H, (15)N, and (13)C resonance assignments and secondary structure of the Tollip CUE domain","volume":"30","author":"Azurmendi","year":"2010","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbadis.2025.167761_bb0700","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2004.03.009","article-title":"Characterization of Tollip protein upon lipopolysaccharide challenge","volume":"41","author":"Li","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0705","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4049\/jimmunol.167.2.987","volume":"167","author":"Bulut","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0710","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.cub.2006.09.062","article-title":"Intracellular trafficking of interleukin-1 receptor I requires Tollip","volume":"16","author":"Brissoni","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0715","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1742-2094-9-271","article-title":"PINK1 positively regulates IL-1\u03b2-mediated signaling through Tollip and IRAK1 modulation","volume":"9","author":"Lee","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2025.167761_bb0720","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/MCB.26.3.735-742.2006","article-title":"Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide","volume":"26","author":"Didierlaurent","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0725","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1074\/jbc.M114.611442","article-title":"Alteration of lysosome fusion and low-grade inflammation mediated by super-low-dose endotoxin","volume":"290","author":"Baker","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0730","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature04768","article-title":"Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4","volume":"441","author":"Gilchrist","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0735","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.4049\/jimmunol.179.6.3622","article-title":"Negative regulation of TLR-signaling pathways by activating transcription factor-3","volume":"179","author":"Whitmore","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0740","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/cdd.2009.2","article-title":"ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress","volume":"16","author":"Turchi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2025.167761_bb0745","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ni.1721","article-title":"Function of C\/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals","volume":"10","author":"Litvak","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0750","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167761_bb0755","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0760","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0765","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0770","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat Rev Gastroneterol Hepatol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0775","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function","volume":"207","author":"Sander","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4291\/wjgp.v6.i3.43","article-title":"Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis","volume":"6","author":"Hammerich","year":"2015","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0785","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0005-2760(96)00041-0","article-title":"Chylomicron assembly and catabolism: role of apolipoproteins and receptors","volume":"1300","author":"Hussain","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167761_bb0790","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.nutr.20.1.169","article-title":"APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation","volume":"20","author":"Davidson","year":"2000","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.bbadis.2025.167761_bb0795","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2025.167761_bb0800","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2025.167761_bb0805","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1017\/S0007114513000639","article-title":"Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats","volume":"110","author":"Parolini","year":"2013","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbadis.2025.167761_bb0810","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R084020","article-title":"Lipid transfer proteins: introduction to the thematic review series","volume":"59","author":"Getz","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0815","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1194\/jlr.R083451","article-title":"Lipid transfer proteins in the assembly of apoB-containing lipoproteins","volume":"59","author":"Sirwi","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0820","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0021-9258(18)61650-3","article-title":"Purification and characterization of a human plasma cholesteryl ester transfer protein","volume":"262","author":"Hesler","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0825","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00041433-199806000-00004","article-title":"Structure and function of the plasma phospholipid transfer protein","volume":"9","author":"Lagrost","year":"1998","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0830","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly","volume":"44","author":"Hussain","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0835","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1194\/jlr.R082313","article-title":"Is ABCA1 a lipid transfer protein?","volume":"59","author":"Phillips","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0840","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1388-1981(00)00157-8","article-title":"Tangier disease and ABCA1","volume":"1529","author":"Oram","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167761_bb0845","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.R082933","article-title":"Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization","volume":"59","author":"Glatz","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0850","doi-asserted-by":"crossref","first-page":"17665","DOI":"10.1016\/S0021-9258(17)46753-6","article-title":"Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36","volume":"268","author":"Abumrad","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0855","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","article-title":"CD36 is a receptor for oxidized low density lipoprotein","volume":"268","author":"Endemann","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0860","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0888-7543(95)80114-2","article-title":"The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution","volume":"25","author":"Calvo","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2025.167761_bb0865","doi-asserted-by":"crossref","first-page":"31002","DOI":"10.1074\/jbc.M602794200","article-title":"Membrane sorting of toll-like receptor (TLR)-2\/6 and TLR2\/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting","volume":"281","author":"Triantafilou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0870","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1083\/jcb.200501113","article-title":"Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain","volume":"170","author":"Stuart","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0875","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature03253","article-title":"CD36 is a sensor of diacylglycerides","volume":"433","author":"Hoebe","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167761_bb0880","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0885","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbadis.2010.07.002","article-title":"The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease","volume":"1812","author":"Marchesi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167761_bb0890","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-811X-10-21","article-title":"Functions of the Lyn tyrosine kinase in health and disease","volume":"10","author":"Ingley","year":"2012","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbadis.2025.167761_bb0895","doi-asserted-by":"crossref","first-page":"22315","DOI":"10.1074\/jbc.271.37.22315","article-title":"CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails","volume":"271","author":"Tao","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0900","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1194\/jlr.R083121","article-title":"Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function","volume":"59","author":"Shen","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0905","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.80.17.5435","article-title":"Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad","volume":"80","author":"Pittman","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167761_bb0910","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0005-2760(83)90237-0","article-title":"Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether","volume":"752","author":"Stein","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2025.167761_bb0915","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb0920","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","article-title":"The many roles of cholesterol in sepsis: a review","volume":"205","author":"Hofmaenner","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0925","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-023-01004-2","article-title":"Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease","volume":"118","author":"Guillas","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0930","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0935","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10557-018-06846-w","article-title":"High-density lipoprotein function and dysfunction in health and disease","volume":"33","author":"Chiesa","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbadis.2025.167761_bb0940","doi-asserted-by":"crossref","first-page":"12965","DOI":"10.3390\/ijms232112965","article-title":"Impact of high-density lipoproteins on sepsis","volume":"23","author":"De Geest","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167761_bb0945","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/ATVBAHA.124.320851","article-title":"Interactions between HDL and CD4+ T cells: a novel understanding of HDL anti-inflammatory properties","volume":"44","author":"Atehortua","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0950","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb0955","article-title":"The HDL proteome watch: compilation of studies leads to new insights on HDL function","volume":"1867","author":"Davidson","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbadis.2025.167761_bb0960","article-title":"The apoM\/S1P complex-a mediator in kidney biology and disease?","volume":"14","author":"Bisgaard","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.bbadis.2025.167761_bb0965","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1160\/TH15-10-0831","article-title":"L-homoarginine administration reduces neointimal hyperplasia in balloon-injured rat carotids","volume":"116","author":"Dellera","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2025.167761_bb0970","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb0975","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tcm.2005.08.005","article-title":"Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids","volume":"15","author":"Nofer","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb0980","doi-asserted-by":"crossref","first-page":"20156","DOI":"10.1016\/S0021-9258(20)80707-8","article-title":"Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction","volume":"268","author":"Subbaiah","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0985","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1074\/jbc.271.8.4243","article-title":"The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins","volume":"271","author":"Rye","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb0990","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1194\/jlr.M500531-JLR200","article-title":"Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I","volume":"47","author":"Duong","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb0995","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis","volume":"29","author":"Zerrad-Saadi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1000","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","article-title":"Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity","volume":"197","author":"de Souza","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1582-4934.2009.00713.x","article-title":"Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I","volume":"14","author":"de Souza","year":"2010","journal-title":"J Cellk Mol Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1010","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.107.145672","article-title":"Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities","volume":"27","author":"Kontush","year":"2007","journal-title":"Artherioscler Thromb Vasc Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1194\/jlr.R059543","article-title":"Sources, metabolism, and regulation of circulating sphingosine-1-phosphate","volume":"56","author":"Ksiazek","year":"2015","journal-title":"L Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","article-title":"Vascular endothelium as a contributor of plasma sphingosine 1-phosphate","volume":"102","author":"Venkataraman","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1025","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1096\/fj.06-7433com","article-title":"Erythrocytes store and release sphingosine 1-phosphate in blood","volume":"21","author":"H\u00e4nel","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2025.167761_bb1030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni.1939","article-title":"The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells","volume":"11","author":"Liu","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1035","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1038\/s41598-017-13376-2","article-title":"S1P1 deletion differentially affects TH17 and regulatory T cells","volume":"7","author":"Eken","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167761_bb1040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2174\/157016109789043856","article-title":"HDL therapy for the treatment of cardiovascular diseases","volume":"7","author":"Parolini","year":"2009","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.E012138","article-title":"The role of HDL in innate immunity","volume":"52","author":"Feingold","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tem.2010.10.001","article-title":"High density lipoprotein: it\u2019s not just about lipid transport anymore","volume":"22","author":"Gordon","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2025.167761_bb1055","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI109252","article-title":"The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum","volume":"62","author":"Ulevitch","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb1060","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6729","article-title":"Enterically derived high-density lipoprotein restrains liver injury through the portal vein","volume":"373","author":"Han","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb1065","article-title":"ApoM binds endotoxin contributing to neutralization and clearance by high density lipoprotein","volume":"34","author":"Mousa","year":"2023","journal-title":"Biochem Biophys Rep."},{"key":"10.1016\/j.bbadis.2025.167761_bb1070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehu264","article-title":"HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative","volume":"36","author":"Martin","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2025.167761_bb1075","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.atherosclerosis.2016.06.019","article-title":"Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial","volume":"251","author":"Albers","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003246-199604000-00006","article-title":"Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia","volume":"24","author":"Gordon","year":"1996","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1085","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"Van Leeuwen","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13613-019-0541-8","article-title":"High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients","volume":"9","author":"Tanaka","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.bbadis.2025.167761_bb1095","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcrc.2015.01.001","article-title":"Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission","volume":"30","author":"Chien","year":"2015","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.bbadis.2025.167761_bb1100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcrc.2016.11.041","article-title":"Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis","volume":"38","author":"Cirstea","year":"2017","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.bbadis.2025.167761_bb1105","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.12601","article-title":"Two-year follow-up of patients with septic shock presenting with low HDL: the effect upon acute kidney injury, death and estimated glomerular filtration rate","volume":"281","author":"Roveran Genga","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1110","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10096-019-03543-w","article-title":"The impact of bacteremia on lipoprotein concentrations and patient\u2019s outcome: a retrospective analysis","volume":"38","author":"Pizzini","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bbadis.2025.167761_bb1115","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1074\/jbc.M112.442699","article-title":"High density lipoprotein protects against polymicrobe-induced sepsis in mice","volume":"21","author":"Guo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1120","first-page":"13","article-title":"Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956\/1","author":"Parolini","year":"2014","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.bbadis.2025.167761_bb1125","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/ATVBAHA.113.302484","article-title":"Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis","volume":"34","author":"Guo","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cvr\/cvz138","article-title":"Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis","volume":"116","author":"Galle-Treger","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCRESAHA.112.280081","article-title":"Scavenger receptor class B type I is a plasma membrane cholesterol sensor","volume":"112","author":"Saddar","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107974","article-title":"Elevated free cholesterol levels due to impaired reverse cholesterol transport are a risk factor for polymicrobial sepsis in mice","volume":"300","author":"Wang","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1145","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000860","article-title":"Association between hypocholesterolemia and mortality in critically ill patients with sepsis: a systematic review and meta-analysis","volume":"5","author":"Hofmaenner","year":"2023","journal-title":"Crit Care Explor."},{"key":"10.1016\/j.bbadis.2025.167761_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104981","article-title":"Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies","volume":"100","author":"Taylor","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2025.167761_bb1155","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/imm.12638","article-title":"High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation","volume":"149","author":"Thacker","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.bbadis.2025.167761_bb1160","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167761_bb1165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1096\/fj.13-233874","article-title":"High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1\u03b1","volume":"28","author":"Tan","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2025.167761_bb1175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbrc.2014.12.028","article-title":"SR-BI mediates high density lipoprotein (HDL)-induced anti-inflammatory effect in macrophages","volume":"457","author":"Song","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.167761_bb1180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nri.2016.136","article-title":"Disease tolerance and immunity in host protection against infection","volume":"17","author":"Soares","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1185","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.128.3326.714","article-title":"Tolerance to cereal leaf rusts","volume":"128","author":"Caldwell","year":"1958","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb1190","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1189731","article-title":"ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation","volume":"328","author":"Yvan-Charvet","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167761_bb1195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1200","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.1402870","article-title":"High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function","volume":"194","author":"Tiniakou","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1205","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","article-title":"Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity","volume":"25","author":"Westerterp","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.167761_bb1210","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb1215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.107.161711","article-title":"Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1","volume":"102","author":"Out","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.107.156935","article-title":"Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels","volume":"28","author":"Out","year":"2008","journal-title":"Arteriosclr Thromb Vasc Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1225","doi-asserted-by":"crossref","first-page":"36158","DOI":"10.1074\/jbc.M110.134130","article-title":"Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr\u2212\/\u2212, ApoA-I\u2212\/\u2212 mice","volume":"285","author":"Wilhelm","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1230","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2025.167761_bb1235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trsl.2016.02.008","article-title":"Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy","volume":"173","author":"Annema","year":"2016","journal-title":"TRanl Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1240","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2025.167761_bb1245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOL.0000000000000825","article-title":"Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment","volume":"33","author":"Therond","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1250","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb1255","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation n of Toll-like receptor 2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2025.167761_bb1260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-016-2895-7","article-title":"High-density lipoprotein from subjects with coronary artery disease promotes macrophage foam cell formation: role of scavenger receptor CD36 and ERK\/MAPK signaling","volume":"427","author":"Sini","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/SHK.0000000000001030","article-title":"HDL cholesterol efflux is impaired in older patients with early sepsis: a subanalysis of a prospective pilot study","volume":"50","author":"Guirgis","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.bbadis.2025.167761_bb1270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12931-020-01553-3","article-title":"The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice","volume":"21","author":"Yang","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1275","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2025.167761_bb1280","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehx665","article-title":"U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies","volume":"39","author":"Madsen","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2025.167761_bb1285","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","article-title":"Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit","volume":"85","author":"Badimon","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb1295","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cjca.2019.05.033","article-title":"Infusions of large synthetic HDL containing trimeric apoA-I stabilize atherosclerotic plaques in hypercholesterolemic rabbits","volume":"35","author":"Parolini","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1300","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/j.jacl.2024.01.009","article-title":"High-density lipoprotein infusion therapy: a review","volume":"18","author":"Brewer","year":"2024","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1305","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/ijms22115980","article-title":"Multifaced roles of HDL in sepsis and SARS-CoV-2 infection: renal implications","volume":"22","author":"Stasi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167761_bb1310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108684","article-title":"HDL-based therapeutics: a promising frontier in combating viral and bacterial infections","volume":"260","author":"Rani","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2025.167761_bb1315","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","article-title":"In vivo protection against endotoxin by plasma high density lipoprotein","volume":"90","author":"Levine","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167761_bb1320","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1002\/pmic.200401292","article-title":"Reference maps of mouse serum acute-phase proteins: changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes","volume":"5","author":"Wait","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2025.167761_bb1325","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1006\/jsre.1995.1204","article-title":"Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha","volume":"59","author":"Casas","year":"1995","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00024382-199703000-00004","article-title":"Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells","volume":"7","author":"Moudry","year":"1997","journal-title":"Shock"},{"key":"10.1016\/j.bbadis.2025.167761_bb1335","first-page":"548","article-title":"Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models","volume":"126","author":"Hubsch","year":"1995","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1340","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9880.1000172","article-title":"HDL mimetic peptide administration improves left ventricular filling and cardiac output in lipopolysaccharide-treated rats","volume":"2","author":"Datta","year":"2011","journal-title":"J Clin Exp Cardiolog."},{"key":"10.1016\/j.bbadis.2025.167761_bb1345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064486","article-title":"Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis","volume":"8","author":"Sharifov","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2025.167761_bb1350","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/TA.0b013e3182493ab4","article-title":"4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats","volume":"72","author":"Kwon","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.bbadis.2025.167761_bb1355","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0000000000003155","article-title":"Reconstituted high-density lipoprotein therapy improves survival in mouse models of sepsis","volume":"132","author":"Tanaka","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbadis.2025.167761_bb1360","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2025.167761_bb1365","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2011.04.001","article-title":"The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins","volume":"217","author":"Di Bartolo","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1370","doi-asserted-by":"crossref","first-page":"eabl9322","DOI":"10.1126\/scisignal.abl9322","article-title":"Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice","volume":"15","author":"Guo","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbadis.2025.167761_bb1375","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ahj.2015.01.008","article-title":"The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: the Modifying Orphan Disease Evaluation (MODE) study","volume":"169","author":"Hovingh","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbadis.2025.167761_bb1380","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12916-023-03057-5","article-title":"Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project","volume":"21","author":"Stasi","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1385","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.184.5.1601","article-title":"Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia","volume":"184","author":"Pajkrt","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1390","doi-asserted-by":"crossref","first-page":"H866","DOI":"10.1152\/ajpheart.01232.2008","article-title":"Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1395","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jacc.2007.12.010","volume":"51","author":"Parolini","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1400","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00003246-199603000-00013","article-title":"Pharmacokinetics of reconstituted human high-density lipoprotein in pigs after hemorrhagic shock with resuscitation","volume":"24","author":"DiPiro","year":"1996","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1405","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/01.RES.76.3.405","article-title":"Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits","volume":"76","author":"Soma","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1410","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1074\/jbc.M207335200","article-title":"Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion","volume":"278","author":"Parolini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1415","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2005.03.008","article-title":"Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model","volume":"183","author":"Parolini","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1420","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1478-3231.2012.02855.x","article-title":"Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant","volume":"32","author":"Parolini","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2025.167761_bb1425","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.ATV.19.5.1257","article-title":"Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice","volume":"19","author":"Franceschini","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1430","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2011.10.006","article-title":"Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)","volume":"220","author":"Ibanez","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1435","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1194\/jlr.M054767","article-title":"ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP\/PKA activation","volume":"56","author":"Lindahl","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.167761_bb1440","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/hsz-2014-0188","article-title":"Recombinant HDL (Milano) protects endotoxin-challenged rats from multiple organ injury and dysfunction","volume":"396","author":"Zhang","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1445","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.ATV.7.4.426","article-title":"Apolipoprotein A-IMilano. Correlation between high density lipoprotein subclass distribution and triglyceridemia","volume":"7","author":"Franceschini","year":"1987","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.bbadis.2025.167761_bb1450","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1074\/jbc.M609336200","article-title":"A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding cassette A1-mediated cell cholesterol efflux","volume":"282","author":"Favari","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1455","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1016\/S0021-9258(19)38334-6","article-title":"Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma","volume":"265","author":"Franceschini","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167761_bb1460","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1172\/JCI116349","article-title":"In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia","volume":"91","author":"Roma","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167761_bb1465","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cyto.2015.02.025","article-title":"Toll-like receptors: activation, signalling and transcriptional modulation","volume":"74","author":"De Nardo","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bbadis.2025.167761_bb1470","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1182\/blood-2011-04-345330","article-title":"Transcriptomic analyses of murine resolution-phase macrophages","volume":"118","author":"Stables","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2025.167761_bb1475","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fimmu.2020.01273","article-title":"Role of MIF cytokine\/CD74 receptor pathway in protecting against injury and promoting repair","volume":"11","author":"Farr","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1480","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.4049\/jimmunol.179.8.5474","article-title":"The chemokine CCL6 promotes innate immunity via immune cell activation and recruitment","volume":"179","author":"Coelho","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2025.167761_bb1485","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1197432","article-title":"Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions","volume":"10","author":"den Hartigh","year":"2023","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.bbadis.2025.167761_bb1490","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jacl.2023.07.003","article-title":"Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia","volume":"17","author":"Darabi","year":"2023","journal-title":"J Clin Lipid."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:33:02Z","timestamp":1749558782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":297,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0925443925001061"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167761","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sepsis and high-density lipoproteins: Pathophysiology and potential new therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167761"}}